ijms-logo

Journal Browser

Journal Browser

The New Molecular Mechanism of Preterm Birth

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 7728

Special Issue Editor


E-Mail Website
Guest Editor
Department of Obstetrics and Gynecology, Ewha Womans University, Seoul, Korea
Interests: preterm birth; fetal programming; microbiota; metabolites; infection; Lactobacillus

Special Issue Information

Dear Colleagues,

Preterm birth (PTB) remains the biggest challenge in obstetrics, and a better understating of underlying cellular and molecular mechanisms is needed. Genetic alterations, environmental toxicants, or an internal infection may cause uterine distention, maternal-fetal oxidative stress, or cervical dysfunction, which trigger parturition to spontaneous preterm labor (PTL) or preterm premature rupture of membrane (PPROM). Advancement in molecular techniques such as metagenomics, microbiomics, and metabolomics opens a new horizon to elucidate the precise cellular and molecular signaling pathway of PTB. Microbiota dysbiosis might directly affect the production of microbiota-generated metabolites and lead to metabolic dysfunction in immune response and maternal-uterine or fetal cellular membranes (amnion and chorion), which stimulate the inflammatory cytokines (IL-6, TNF-a) signaling pathway and induce PTB. The detection of omics markers in maternal bio-fluid (plasma, cervicovaginal, and amniotic fluid) at different trimesters, in a well-defined population, could reveal the accurate cellular and molecular mechanisms, predictive biomarkers, and biotics/therapeutics development for PTB.

Dr. Young Ju Kim
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Preterm
  • Microbiota
  • Metabolites
  • Metabolomics
  • Metagenomics
  • Microbiomics
  • Biomarkers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

12 pages, 318 KiB  
Review
The Role of Antimicrobial Peptides in Preterm Birth
by Ga-Hyun Son, Jae-Jun Lee, Youngmi Kim and Keun-Young Lee
Int. J. Mol. Sci. 2021, 22(16), 8905; https://doi.org/10.3390/ijms22168905 - 18 Aug 2021
Cited by 13 | Viewed by 2717
Abstract
Antimicrobial peptides (AMPs) are short cationic amphipathic peptides with a wide range of antimicrobial properties and play an important role in the maintenance of immune homeostasis by modulating immune responses in the reproductive tract. As intra-amniotic infection and microbial dysbiosis emerge as common [...] Read more.
Antimicrobial peptides (AMPs) are short cationic amphipathic peptides with a wide range of antimicrobial properties and play an important role in the maintenance of immune homeostasis by modulating immune responses in the reproductive tract. As intra-amniotic infection and microbial dysbiosis emerge as common causes of preterm births (PTBs), a better understanding of the AMPs involved in the development of PTB is essential. The altered expression of AMPs has been reported in PTB-related clinical presentations, such as preterm labor, intra-amniotic infection/inflammation, premature rupture of membranes, and cervical insufficiency. Moreover, it was previously reported that dysregulation of AMPs may affect the pregnancy prognosis. This review aims to describe the expression of AMPs associated with PTBs and to provide new perspectives on the role of AMPs in PTB. Full article
(This article belongs to the Special Issue The New Molecular Mechanism of Preterm Birth)
20 pages, 3901 KiB  
Review
Molecular Mechanism of Microbiota Metabolites in Preterm Birth: Pathological and Therapeutic Insights
by AbuZar Ansari, Shambhunath Bose, Youngah You, Sunwha Park and Youngju Kim
Int. J. Mol. Sci. 2021, 22(15), 8145; https://doi.org/10.3390/ijms22158145 - 29 Jul 2021
Cited by 21 | Viewed by 4277
Abstract
Preterm birth (PTB) refers to the birth of infants before 37 weeks of gestation and is a challenging issue worldwide. Evidence reveals that PTB is a multifactorial dysregulation mediated by a complex molecular mechanism. Thus, a better understanding of the complex molecular mechanisms [...] Read more.
Preterm birth (PTB) refers to the birth of infants before 37 weeks of gestation and is a challenging issue worldwide. Evidence reveals that PTB is a multifactorial dysregulation mediated by a complex molecular mechanism. Thus, a better understanding of the complex molecular mechanisms underlying PTB is a prerequisite to explore effective therapeutic approaches. During early pregnancy, various physiological and metabolic changes occur as a result of endocrine and immune metabolism. The microbiota controls the physiological and metabolic mechanism of the host homeostasis, and dysbiosis of maternal microbial homeostasis dysregulates the mechanistic of fetal developmental processes and directly affects the birth outcome. Accumulating evidence indicates that metabolic dysregulation in the maternal or fetal membranes stimulates the inflammatory cytokines, which may positively progress the PTB. Although labour is regarded as an inflammatory process, it is still unclear how microbial dysbiosis could regulate the molecular mechanism of PTB. In this review based on recent research, we focused on both the pathological and therapeutic contribution of microbiota-generated metabolites to PTB and the possible molecular mechanisms. Full article
(This article belongs to the Special Issue The New Molecular Mechanism of Preterm Birth)
Show Figures

Figure 1

Back to TopTop